Market Currents
More on Monster Beverage (MNST) (previous): Goldman Sachs calls the response from the FDA on the...
-
Tuesday, November 27, 2012, 1:12 PM ETMore on Monster Beverage (MNST) (previous): Goldman Sachs calls the response from the FDA on the energy drink health concerns relatively "benign" and encouraging for shareholders of the company. The common sense approach by consumers is likely to be moderation and increased oversight by parents - instead of anything resembling a ban or graphic warning labels. MNST +12.5% to $51.50.
Other date
Latest Consumer Articles
This news story has 2 comments:
http://seekingalpha.co...